Skeletal Muscle Index And Ovarian Cancer Prognosis: A Meta-Analysis

Skeletal Muscle Index And Ovarian Cancer Prognosis: A Meta-Analysis Overview In this study, a meta-analysis was carried out to determine the correlation between low skeletal muscle index (SMI) and the clinicopathological features and prognosis of patients with ovarian cancer. Advances in the ability to predict the overall survival rate and prognosis of ovarian

Osteopenia predicts outcomes in pancreatic cancer

Osteopenia predicts outcomes in pancreatic cancer Study Background Pancreatic ductal adenocarcinoma (PDAC) is the third leading cause of cancer deaths in the United States and is projected to become the second by 2030. The unfavorable prognosis of PDAC can be attributed to late diagnosis, poor metabolic status, and the resistance of cancer

Skeletal Muscle Index And Ovarian Cancer Prognosis: A Meta-Analysis